A synthetic cohort analysis of postoperative management of primary cardiac angiosarcoma and a case report

作者：Ying Cai, Hang Yang, Dan Yuan, Su‐Han Jin, Junzhu Xu, Wei Hu, Yuju Bai, Xinjuan Li, Zejin Wang, Dengshen Zhang, Ke Guo, Shixiang Wang, Udo S. Gaipl, Yuan Liu, Hu Ma, Jian‐Guo Zhou · 发表于：Frontiers in Oncology · 年份：2025 · DOI：10.3389/fonc.2025.1625049 · 被引用次数：2 · 研究领域：Cardiac tumors and thrombi、Vascular Tumors and Angiosarcomas、Sarcoma Diagnosis and Treatment

Background: Primary cardiac angiosarcoma is a rare and aggressive malignancy originating from the endothelial lining of cardiac blood vessels. The prognosis remains extremely poor. The study was to evaluate postoperative survival in patients with primary cardiac angiosarcoma after treated with adjuvant therapy. Methods: A systematic review of PubMed from January 1985 to December 2023 was performed to establish a synthetic cohort of patients undergoing surgery for primary cardiac angiosarcoma. Survival analysis was used to assess the relationship between postoperative adjuvant therapy and prognosis. Univariable and multivariable cox regression analyses were used to identify prognostic factors. We then established and validated a nomogram by receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA). Moreover, we present a case of 49-year-old patient with primary cardiac angiosarcoma. Results: In the synthetic cohort, the patients with postoperative adjuvant therapy reached longer overall survival (OS) and progression-free survival (PFS) than those without postoperative adjuvant therapy (median OS: 14 VS 8 months, HR = 5.62, 95%CI: 1.66-19.08, P<0.001; median PFS: 12 VS 6 months, HR = 2.98, 95%CI: 1.03-8.66, P = 0.007; Log rank test). Radiotherapy (HR = 0.14, 95% CI: 0.04-0.54, P = 0.004) and chemotherapy (HR = 0.03, 95% CI: 0.00-0.27, P = 0.002) were significantly correlated with better OS. DCA and ROC curves confirmed the nomogram can...